Entry Detail



General Information

Database ID:exR0082996
RNA Name:TKT
RNA Type:mRNA
Chromosome:chr3
Starnd:-
Coordinate:
Start Site(bp):53224712End Site(bp):53256052
External Links:ENSG00000163931



Disease Information

Disease Name:Fragile X Syndrome
Disease Category:Congenital, Hereditary, and Neonatal Diseases and Abnormalities
MeSH ID:D005600
Type:Diseases Category/Congenital, Hereditary, and Neonatal Diseases and Abnormalities
Alias:Fragile X Syndromes//Syndrome, Fragile X//Syndromes, Fragile X//Marker X Syndrome//Marker X Syndromes//Syndrome, Marker X//Syndromes, Marker X//Mental Retardation, X-Linked, Associated With Marxq28//X-Linked Mental Retardation and Macroorchidism//X Linked Mental Retardation and Macroorchidism//Fragile X Mental Retardation Syndrome//Martin-Bell Syndrome//Martin Bell Syndrome//Syndrome, Martin-Bell//Fra(X) Syndrome//FRAXE Syndrome//FRAXE Syndromes//Syndrome, FRAXE//Syndromes, FRAXE//Mental Retardation, X-Linked, Associated With Fragile Site Fraxe//Fragile X-F Mental Retardation Syndrome//Mar (X) Syndrome//FRAXA Syndrome//FRAXA Syndromes//Syndrome, FRAXA//Syndromes, FRAXA



Expression Detail

GEO ID:GSE83556
Description:Global transcriptome dysregulation in second trimester fetuses with FMR1 expansions
Experimental Design:Disease vs Control
Case Disease Type:Fragile X Syndrome
Case Disease SubType:NA
Case Sample:Fragile X Syndrome
Control Sample:Normal
Number of Case:22
Number of Control:18
Number of Samples:40





Regulatory Relationship

mRNA targets:
Gene SymbolChromosomeStart Site(bp)End Site(bp)Strand
ABCF1
chr6
30571393
30597179
+
AC104532.1
chr19
5904841
5914707
+
AC245033.1
chr15
82536788
82573194
-
AC124312.1
chr15
24955034
25000276
+
AC008982.1
chr19
38817471
38840178
-
ACTR1A
chr10
102461881
102502712
-
ALDOA
chr16
30064164
30070457
+
ACO2
chr22
41469117
41528989
+
ACAP1
chr17
7336529
7351477
+
ABCA2
chr9
137007234
137028922
-
AC104109.3
chr5
134167170
134226071
-
ACLY
chr17
41866917
41930542
-
AC004922.1
chr7
99325879
99394653
+
AC068580.4
chr11
1734821
1763954
-
AL136454.1
chr1
192716132
192716653
+
AD000671.2
chr19
35739252
35745432
-
AGO4
chr1
35808016
35857890
+
AC138969.1
chr16
16317444
16350590
+
ACTB
chr7
5527148
5563784
-
AC007192.1
chr19
18153158
18178117
+
ADAR
chr1
154582057
154628013
-
ACTG1
chr17
81509971
81523847
-
AKT1
chr14
104769349
104795751
-
AC010615.4
chr19
21405159
21491266
+
AC018523.2
chr11
14493783
14520344
-
AC004832.3
chr22
30409255
30428990
+
ADSL
chr22
40346500
40390463
+
AKAP12
chr6
151239967
151358559
+
AL022238.4
chr22
40346529
40410054
+
ADRM1
chr20
62302093
62308862
+
miRNA targets:NA
circRNA targets:NA
lncRNA targets:
lncRNA SymbolChromosomeStart Site(bp)End Site(bp)Strand
AC012236.1
chr15
31221999
31230838
-
AC087521.3
chr11
43921059
44001157
+
AC091564.7
chr11
6610883
6616594
-
AC091729.3
chr7
1160374
1165607
+
AC245014.3
chr1
145281116
145281462
+
AD000090.1
chr19
35557956
35581954
+
AL031282.2
chr1
1702736
1737688
-
Display:



Experiment Detail

GEO ID:GSE83556
Sample Source:Amniotic Fluid
Source Fraction:Supernatant
Platform:GPL570
Method:Microarray
Num of detected RNA Type:1
Num of detected RNAs of this Type:17063
Sample treatment protocol:RNA was extracted from 5-15 mL amniotic fluid supernatant (centrifugation at 350g, 4C, 10, min).
RNA Extract protocol:All samples were processed using the Qiagen Circulating Nucleic Acid kit with an on-column DNase digestion step to remove genomic DNA. The RNA was then purified and concentrated with the RNeasy MinElute Clean up kit and eluted in RNasefree water.
RNA library preparation protocol:RNA was converted to cDNA and amplified using the Ovation Pico WTA kit V2 and then purified with the QIAquick PCR Purification kit. Samples were labeled using the Encore Biotin Module (NuGEN, San Carlos, CA)Samples were labeled using the Encore Biotin Module (NuGEN, San Carlos, CA).



Reference

PMID:NA
Title:NA
Author:NA
Journal:NA
Description:NA